Lipigon Pharmaceuticals AB - ESG Rating & Company Profile powered by AI
The Disclosure score covers 17 UN Sustainable Development Goals including: 'Good Health & Wellbeing', 'Sustainable Cities & Communities' and 'Peace, Justice & Strong Institutions'. If you are employed by Lipigon Pharmaceuticals AB and you would like to use your Sustainability aseessment, please get in touch. The page contains a Q&A table for Lipigon Pharmaceuticals AB.
Lipigon Pharmaceuticals AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.8; made up of an environmental score of 4.0, social score of 8.0 and governance score of 5.3.
5.8
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
521 | Smruthi Organics Ltd | 5.9 | High |
521 | Vectura Group PLC | 5.9 | High |
541 | Lipigon Pharmaceuticals AB | 5.8 | High |
541 | Cantargia AB | 5.8 | High |
541 | Amplia Therapeutics Ltd | 5.8 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Lipigon Pharmaceuticals AB have an accelerator or VC vehicle to help deliver innovation?
Does Lipigon Pharmaceuticals AB disclose current and historical energy intensity?
Does Lipigon Pharmaceuticals AB report the average age of the workforce?
Does Lipigon Pharmaceuticals AB reference operational or capital allocation in relation to climate change?
Does Lipigon Pharmaceuticals AB disclose its ethnicity pay gap?
Does Lipigon Pharmaceuticals AB disclose cybersecurity risks?
Does Lipigon Pharmaceuticals AB offer flexible work?
Does Lipigon Pharmaceuticals AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Lipigon Pharmaceuticals AB disclose the number of employees in R&D functions?
Does Lipigon Pharmaceuticals AB conduct supply chain audits?
Does Lipigon Pharmaceuticals AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Lipigon Pharmaceuticals AB conduct 360 degree staff reviews?
Does Lipigon Pharmaceuticals AB disclose the individual responsible for D&I?
Does Lipigon Pharmaceuticals AB disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Lipigon Pharmaceuticals AB disclose current and / or historical scope 2 emissions?
Does Lipigon Pharmaceuticals AB disclose water use targets?
Does Lipigon Pharmaceuticals AB have careers partnerships with academic institutions?
Did Lipigon Pharmaceuticals AB have a product recall in the last two years?
Does Lipigon Pharmaceuticals AB disclose incidents of discrimination?
Does Lipigon Pharmaceuticals AB allow for Work Councils/Collective Agreements to be formed?
Has Lipigon Pharmaceuticals AB issued a profit warning in the past 24 months?
Does Lipigon Pharmaceuticals AB disclose parental leave metrics?
Does Lipigon Pharmaceuticals AB disclose climate scenario or pathway analysis?
Does Lipigon Pharmaceuticals AB disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Lipigon Pharmaceuticals AB disclose the pay ratio of women to men?
Does Lipigon Pharmaceuticals AB support suppliers with sustainability related research and development?
Does Lipigon Pharmaceuticals AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Lipigon Pharmaceuticals AB reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Lipigon Pharmaceuticals AB involved in embryonic stem cell research?
Does Lipigon Pharmaceuticals AB disclose GHG and Air Emissions intensity?
Does Lipigon Pharmaceuticals AB disclose its waste policy?
Does Lipigon Pharmaceuticals AB report according to TCFD requirements?
Does Lipigon Pharmaceuticals AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Lipigon Pharmaceuticals AB disclose energy use targets?
Does Lipigon Pharmaceuticals AB disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Lipigon Pharmaceuticals AB have a policy relating to cyber security?
Have a different question?
Potential Risks for Lipigon Pharmaceuticals AB
These potential risks are based on the size, segment and geographies of the company.
Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company's product pipeline consists of Lipisense project for the treatment of severe hypertriglyceridemia disease and familial chylomicronemia syndrome; a gene therapy project for the lipodystrophy, a rare disease of altered fat distribution in the body; therapeutics for dyslipidemia, a general lipid disorder; and RNA drug project for acute respiratory distress syndrome. Lipigon Pharmaceuticals AB (publ) has a collaboration agreement with HitGen Inc. for the development of small molecules for the treatment of dyslipidemia, cardiovascular disease, and other metabolic diseases. The company was founded in 2010 and is based in Umeå, Sweden.